


Searching News Database: excimer laser atherectomy
HSMN NewsFeed - 27 Jan 2015
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
HSMN NewsFeed - 12 Jul 2011
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
HSMN NewsFeed - 31 May 2011
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
Spectranetics Introduces First Advanced System for Simulation of Peripheral Vascular Arterial Occlusions
HSMN NewsFeed - 7 Apr 2011
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
HSMN NewsFeed - 7 Oct 2010
Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer
Spectranetics Announces Retirement of Chairman and CEO Emile J. Geisenheimer
HSMN NewsFeed - 20 Jul 2010
Spectranetics Announces Reimbursement Approval for Laser-Assisted Lead Extraction in Japan
Spectranetics Announces Reimbursement Approval for Laser-Assisted Lead Extraction in Japan
HSMN NewsFeed - 13 Jan 2010
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
HSMN NewsFeed - 3 Dec 2009
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
Spectranetics Announces FDA Clearance of VisiSheath Dilator Sheath, New Lead Management Device
HSMN NewsFeed - 25 Jun 2009
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
HSMN NewsFeed - 5 May 2009
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
Spectranetics Makes Pre-IDE Submission to FDA for the Treatment of In-Stent Restenosis in the Legs
HSMN NewsFeed - 29 Jan 2009
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs
HSMN NewsFeed - 21 Jan 2009
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
HSMN NewsFeed - 22 Oct 2008
Spectranetics Appoints Company Chairman, Emile J. Geisenheimer, as President and Chief Executive Officer
Spectranetics Appoints Company Chairman, Emile J. Geisenheimer, as President and Chief Executive Officer
HSMN NewsFeed - 13 Aug 2008
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
Spectranetics Takes Steps Targeted at Accelerating Vascular Intervention Growth
HSMN NewsFeed - 2 Jun 2008
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Spectranetics Announces Closing of Transaction to Acquire Endovascular Business of Kensey Nash
Additional items found! 1
Members Archive contains
1 additional stories matching:
excimer laser atherectomy
(Password required)
excimer laser atherectomy
(Password required)
